A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies

Table 4 ELISA and IFAT results for not-exposed-to-malaria blood donors

IFAT and ELISA clinical specificities: 99.6% (2145/2152) (CI: 99.4 – 99.9%), equivocal results considered as positive for calculation.

ISSN: 1475-2875